Oliver Stoß

1.4k total citations · 1 hit paper
16 papers, 1.0k citations indexed

About

Oliver Stoß is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Oliver Stoß has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Oliver Stoß's work include HER2/EGFR in Cancer Research (6 papers), RNA and protein synthesis mechanisms (5 papers) and RNA Research and Splicing (5 papers). Oliver Stoß is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), RNA and protein synthesis mechanisms (5 papers) and RNA Research and Splicing (5 papers). Oliver Stoß collaborates with scholars based in Germany, United States and Belgium. Oliver Stoß's co-authors include Stefan Stamm, Josef Rüschoff, Peter Stoilov, Shunchang Jiao, Oleg Gladkov, Julie Hill, Feng-yi Feng, Michaela Lehle, Jian Xu and Keun-Wook Lee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Modern Pathology.

In The Last Decade

Oliver Stoß

16 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

2014 426 citations Eric Van Cutsem, Yung‐Jue Bang et al. Gastric Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oliver Stoß Germany	10	532	471	334	254	138	16	1.0k
Takahiro Kamio Japan	9	775 1.5×	169 0.4×	600 1.8×	313 1.2×	82 0.6×	20	1.1k
Heidi Bissig Switzerland	8	386 0.7×	477 1.0×	165 0.5×	76 0.3×	188 1.4×	8	824
WJ Gullick United Kingdom	8	847 1.6×	448 1.0×	127 0.4×	461 1.8×	211 1.5×	11	1.1k
C R Divgi United States	10	307 0.6×	205 0.4×	150 0.4×	247 1.0×	114 0.8×	11	581
T Hirota Japan	12	399 0.8×	202 0.4×	135 0.4×	143 0.6×	166 1.2×	25	670
NR Lemoine United Kingdom	7	404 0.8×	360 0.8×	81 0.2×	170 0.7×	85 0.6×	9	709
Marco Losa Switzerland	11	456 0.9×	334 0.7×	242 0.7×	26 0.1×	154 1.1×	20	812
W. H. Miller United States	9	486 0.9×	283 0.6×	166 0.5×	104 0.4×	88 0.6×	17	723
Parula Mehta United States	9	315 0.6×	234 0.5×	172 0.5×	69 0.3×	116 0.8×	11	654
Takumi Yamabuki Japan	13	317 0.6×	894 1.9×	197 0.6×	40 0.2×	220 1.6×	29	1.2k

Countries citing papers authored by Oliver Stoß

Since Specialization

Citations

This map shows the geographic impact of Oliver Stoß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Stoß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Stoß more than expected).

Fields of papers citing papers by Oliver Stoß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Stoß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Stoß. The network helps show where Oliver Stoß may publish in the future.

Co-authorship network of co-authors of Oliver Stoß

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Stoß. A scholar is included among the top collaborators of Oliver Stoß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Stoß. Oliver Stoß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Rüschoff, Josef, Iris Nagelmeier, Bharat Jasani, & Oliver Stoß. (2020). ISH-based HER2 diagnostics. Der Pathologe. 42(S1). 62–68. 5 indexed citations

Stoß, Oliver, Andreas H. Scheel, Iris Nagelmeier, et al.. (2015). Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data. Modern Pathology. 28(12). 1528–1534. 42 indexed citations

Cutsem, Eric Van, Yung‐Jue Bang, Feng-yi Feng, et al.. (2014). HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer. 18(3). 476–484. 426 indexed citations breakdown →

Rüschoff, Josef, Iris Nagelmeier, Gustavo Baretton, et al.. (2010). Her2-Diagnostik beim Magenkarzinom: Was ist anders im Vergleich zum Mammakarzinom?. Der Pathologe. 31(3). 208–217. 1 indexed citations

Dowsett, Mitch, Marion Procter, Worta McCaskill‐Stevens, et al.. (2009). Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial. Journal of Clinical Oncology. 27(18). 2962–2969. 146 indexed citations

Lordick, Florian, et al.. (2007). HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer. mediaTUM (Technical University of Munich). 25 indexed citations

Guillén‐Gómez, Elena, et al.. (2006). Expression of the High-Affinity Fluoropyrimidine-Preferring Nucleoside Transporter hCNT1 Correlates with Decreased Disease-Free Survival in Breast Cancer. Oncology. 70(3). 238–244. 26 indexed citations

Stoß, Oliver, Axel Mogk, & Wolfgang Schumann. (2006). Integrative vector for constructing single-copy translational fusions between regulatory regions of Bacillus subtilis and the bgaB reporter gene encoding a heat-stable β-galactosidase. FEMS Microbiology Letters. 150(1). 49–54. 5 indexed citations

Stoß, Oliver, et al.. (2004). p59fyn-mediated phosphorylation regulates the activity of the tissue-specific splicing factor rSLM-1. Molecular and Cellular Neuroscience. 27(1). 8–21. 40 indexed citations

10.

Stoß, Oliver & Thomas Henkel. (2004). Biomedical marker molecules for cancer – current status and perspectives. 3(6). 228–237. 3 indexed citations

11.

Hoffmann, Anke, Michael Becker, Tania Szado, et al.. (2003). Emerging therapeutic targets in chronic heart failure: Part II. Expert Opinion on Therapeutic Targets. 7(1). 49–59. 5 indexed citations

12.

Hoffmann, Anke, Michael Becker, Tania Szado, et al.. (2002). Emerging therapeutic targets in chronic heart failure: Part I. Expert Opinion on Therapeutic Targets. 6(6). 649–658. 3 indexed citations

13.

Stoß, Oliver, Annette M. Hartmann, Harald König, et al.. (2001). The STAR/GSG Family Protein rSLM-2 Regulates the Selection of Alternative Splice Sites. Journal of Biological Chemistry. 276(12). 8665–8673. 86 indexed citations

14.

Stamm, Stefan, Jian Zhu, Kenta Nakai, et al.. (2000). An Alternative-Exon Database and Its Statistical Analysis. DNA and Cell Biology. 19(12). 739–756. 129 indexed citations

15.

Stoß, Oliver, Peter Stoilov, Annette M. Hartmann, Oliver Nayler, & Stefan Stamm. (1999). The in vivo minigene approach to analyze tissue-specific splicing. Brain Research Protocols. 4(3). 383–394. 52 indexed citations

16.

Stoß, Oliver, Franz‐Werner Schwaiger, Thomas A. Cooper, & Stefan Stamm. (1999). Alternative Splicing Determines the Intracellular Localization of the Novel Nuclear Protein Nop30 and Its Interaction with the Splicing Factor SRp30c. Journal of Biological Chemistry. 274(16). 10951–10962. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact